Sterling
Amgen logo
Amgen
Roche logo
Roche

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q1 2026: Amgen 8.618, Roche 17.1305.

* Roche reports semi-annually. Values are evenly split across both quarters within each half.

Amgen vs Roche Net Worth and Market Cap

Amgen (AMGN) and Roche (RHHBY) are peers in GLP-1. Amgen reported revenue of $8.6B as of Q1 2026, compared with $34.3B for Roche. Roche leads on revenue.

Amgen's gross margin is 68.2% versus 71.7% for Roche. Amgen's net margin is 21.1% versus 17.9% for Roche.

Key differences

  • Revenue growth on the same quarter a year earlier: Amgen +5.8% (Q1 2026), Roche -4.2% (Q4 2025).
  • Amgen keeps more of its revenue as operating profit: a 30.9% operating margin, against 23.2% at Roche.
  • Amgen's KPIs on Sterling include AMG 513 Obesity Discontinuation and Cash and Cash Equivalents.
  • Roche's KPIs on Sterling include Carmot Asset Pipeline: CT-388, CT-996, CT-868 Trial Readout Timeline and CT-868 (Acmopatide) Discontinuation.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, Roche.
MetricAmgenRoche
Market Cap--
Revenue$8.62B$34.26B
Cost of Revenue$2.74B$9.68B
Gross Profit$5.87B$24.58B
Operating Income$2.67B$7.96B
Net Income$1.82B$6.13B
R&D Expense$1.72B$7.48B
Earnings Per Share$3.34$0.95
Gross Margin68.2%71.7%
Operating Margin30.9%23.2%
Net Profit Margin21.1%17.9%
Free Cash Flow$1.48B$10.67B
Cumulative Free Cash Flow$165.69B$299.34B
Operating Cash Flow$2.19B$13.12B
Cash & Equivalents$12.04B$6.32B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites